General
Preferred name
DIMETHYLFRAXETIN
Synonyms
Fraxetin dimethyl ether ()
6,7,8-Trimethoxycoumarin ()
6,7,8,-Trimethoxycoumarin ()
FRAXIDIN METHYL ETHER ()
P&D ID
PD002268
CAS
6035-49-0
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Dimethylfraxetin is a Carbonic anhydrase inhibitor, with a Ki value of 0.0097 ¦ÌM.
PRICE
73
DESCRIPTION
Dimethylfraxetin (6,7,8-Trimethoxycoumarin) is a Carbonic anhydrase inhibitor(Ki:0.0097 ??M)
DESCRIPTION
Dimethylfraxetin (6,7,8-Trimethoxycoumarin) is a Carbonic anhydrase inhibitor(Ki:0.0097 μM)
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
5
Cayman Chemical Bioactives
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
22
Molecular Weight
236.07
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
2
cLogP
1.82
TPSA
57.9
Fraction CSP3
0.25
Chiral centers
0.0
Largest ring
6.0
QED
0.76
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Carbonic Anhydrase
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data
